ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 4,620.00
-55.00 (-1.18%)
Nov 2, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 50.96 billion as of October 30, 2026. It is the 31,869th most valuable company in the world and the 1,751st biggest in South Korea. Its market cap has decreased by 59.88% in one year.
Market Cap
50.96B
Enterprise Value
32.70B
Revenue
4.16B
Global Rank
Country Rank
#1,751 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 50.96B, a decrease of -68.31%. That is a compound annual growth rate of -40.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 50.96B | -74.33% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 151.77B |
| Anterogen.Co.,Ltd. | 133.68B |
| MedPacto | 104.54B |
| Genexine | 98.24B |
| Vaxcell-Bio Therapeutics | 86.63B |
| iNtRON Biotechnology | 86.19B |
| Amicogen | 64.54B |
| GeneOne Life Science | 48.42B |